Navigation Links
Biosensors Completes Spectrum Dynamics Assets Acquisition
Date:5/26/2013

SINGAPORE, May 26, 2013 /PRNewswire/ --  Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced the completion of its acquisition of substantially all assets of Spectrum Dynamics, a leader in advanced functional assessment technologies, including those used to evaluate patients for cardiac interventions.  

The deal consideration is approximately US$51 million, with potential earn-out payments upon fulfilling certain performance criteria. Under the terms of the deal, the two companies will also create a joint venture aimed at developing future non-cardiac applications. Biosensors expects the transaction to have minimal impact on its 2014 fiscal year financial results, with the potential to be moderately accretive to its earnings in the following fiscal year. 

"The capacity to uncover and diagnose reversible ischemia prior to catheterization with precision has turned into an essential issue in the treatment of cardiovascular disease. Spectrum Dynamics' advanced imaging systems will facilitate doctors to more effectively establish the appropriate course of treatment for their patients," said Prof. Shlomo Ben-Haim , Co-Founder and Chairman of Spectrum Dynamics. "Biosensors is one of the leading developers of drug-eluting stents. By becoming part of Biosensors' growing family, we hope to actively contribute towards its future growth potential by exploring more opportunities and applications together for better diagnostic solutions for patients."

Dr Jack Wang , CEO of Biosensors said, "We are pleased to have completed this acquisition. With substantially all assets of Spectrum Dynamics under the ownership and management of Biosensors, we are well-positioned to further increase our presence in the global
'/>"/>

SOURCE Biosensors International Group, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biosensors to Acquire Assets of Spectrum Dynamics
2. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
3. Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2013
4. Biosensors Reports Strong Sales and Profitability in the First Quarter of Fiscal Year 2013
5. MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy
6. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
7. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
8. Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device
9. Kite Pharma Completes $35 Million Series A Preferred Stock Financing
10. Vertellus Specialties Completes Upgrades for API Niacin Manufacture
11. Haemonetics Completes Hemerus Medical, LLC Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 According to a ... Extraction type (SFE, Cold Pressed, Organic Solvent, & Others), ... Food Supplements, Fragrance, & Others) - Global Trends & ... segments the Amaranth Seed Oil Market with an ... terms of value. The Amaranth Seed Oil Market ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... Corporation , a neurodiagnostics medical device company based in ... Forcht Dagi , MD, DmedSc, MPH, MBA, FACS, FRCSEd  was ... " Teo Forcht Dagi is an experienced leader with ... said Remis Bistras , President and CEO of Vittamed. ... entrepreneurial expertise to our Board." Dr. Dagi is ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... 5, 2011 Today Scios Inc. announced an agreement with ... misbranding of NATRECOR® (nesiritide), a prescription medication for patients with ... Scios Inc. entered a guilty plea to a single misdemeanor ... to pay an $85 million fine. Scios acknowledges ...
... Puma Biotechnology, Inc., a development stage biopharmaceutical company, ... the worldwide commercial rights to neratinib, a potent, ... through the epidermal growth factor receptors, ErbB1 (EGFR), ... being studied in the neoadjuvant, adjuvant and metastatic ...
Cached Medicine Technology:Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 2Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 3Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 4Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger 5
(Date:9/1/2014)... (PRWEB) September 01, 2014 Registration is now ... Warriors® 5K and 1-Mile Race to be held on Sunday, ... Plaza Court Yard at Harmon Meadow in Secaucus, New Jersey. ... Warriors®, a national nonprofit dedicated to restoring a sense of ... service members and our military families. , General registration is ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... US FDA announced on August 28, that specific lots ... (Class I) as the device may reverse directions ... Synthes Craniomaxillofacial (CMF) Distraction System is an implant used ...
(Date:9/1/2014)... US (PRWEB) September 01, 2014 ... view into Heartbeat Experts’ perspectives on ... market. , Download the flash report to ... for any launching Diabetes product:, ... within an increasingly crowded market , ...
(Date:8/31/2014)... Just in time for Washington’s Indian Summer, ... Alaska Salmon, award winning chowder and legendary sourdough ... Lake location , Sunday, September 28, 2014 from 1 pm ... salmon BBQ culinary delights. Live music will add to the ... Rico and Mexico will be featured. “There is no ...
(Date:8/31/2014)... to celebrate the coming of autumn, Guangdong FODAY Automobile ... big promotion. Now, all the global clients can access cheap, ... are made with great materials. FODAY Automobile strives to offer ... of fact, it is providing big discounts on many of ... cheap cars can visit its website for more details. ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Diabetes Products 2Health News:Seattle Seafood Restaurant Duke's Chowder House on Green Lake Will Celebrate The Long Anticipated Indian Summer With First Annual Sizzling BBQ Salmon Tasting Event. 2
... SMITHFIELD, R.I., July 29 FGX International,(Nasdaq: FGXI ... sunglasses and costume jewelry, today announced financial results,for its ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071025/NETH104LOGO ), ... sales increased 14% to $71.6 million in the current ...
... WHITE PLAINS, N.Y., July 29 Four leaders,from the ... been elected to the national Board of Trustees of ... March of Dimes trustees, who serve as volunteers, represent ... and serve five-year,terms., The new trustees are:, ...
... cancer screening program in Norway and an approach to ... are equally sensitive for detecting cancer, researchers report in ... of the National Cancer Institute . But the recall ... Breast cancer screening in the United States is usually ...
... Income Per Share, SAN JOSE, Calif., July 29 ... leading provider of medical devices,for the minimally invasive treatment ... second quarter ended June 30, 2008., Net revenues ... $31.9,million compared with $17.2 million for the second quarter ...
... (Pink,Sheets: VSMD) announced today that Craig M. Walker, M.D., ... the number of directors from,four to five. Dr. Walker ... cardiologist, clinical investigator and thought leader., "Dr. Walker ... one of the,world,s leading experts in the care of ...
... literacy and,curbing HIV/AIDS is the centerpiece of the U.S. ... stabilize parts of,Haiti plagued by community unrest., The ... -- will,target public and private primary schools as well ... who manages a worldwide education and,health program for USAID., ...
Cached Medicine News:Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 2Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 3Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 4Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 5Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 6Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 7Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 8Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 9Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 10Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 11Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 12Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 13Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 14Health News:Four Named to March of Dimes Board of Trustees 2Health News:Four Named to March of Dimes Board of Trustees 3Health News:Four Named to March of Dimes Board of Trustees 4Health News:Four Named to March of Dimes Board of Trustees 5Health News:Four Named to March of Dimes Board of Trustees 6Health News:Four Named to March of Dimes Board of Trustees 7Health News:2 different breast cancer screening strategies are equally effective 2Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 2Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 3Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 4Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 5Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 6Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 7Health News:VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales 8Health News:VASAMED(R) Appoints Craig M. Walker, MD to Board of Directors 2Health News:Three Rs and HIV/AIDS Mark New Haiti Literacy Plan 2